Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis.

about

Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis.

Item

http://www.wikidata.org/entity/Q36793618

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Monoclonal antibody therapy fo ...... tic reviews and meta-analysis.

@ast

Monoclonal antibody therapy fo ...... tic reviews and meta-analysis.

@en

type

Item

label

Monoclonal antibody therapy fo ...... tic reviews and meta-analysis.

@ast

Monoclonal antibody therapy fo ...... tic reviews and meta-analysis.

@en

prefLabel

Monoclonal antibody therapy fo ...... tic reviews and meta-analysis.

@ast

Monoclonal antibody therapy fo ...... tic reviews and meta-analysis.

@en

P1476

Monoclonal antibody therapy fo ...... tic reviews and meta-analysis.

@en

P2093

Akira Ishiguro

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ono

http://www.w3.org/2001/XMLSchema#string

Osamu Nomura

http://www.w3.org/2001/XMLSchema#string

Sayaka Fukuda

http://www.w3.org/2001/XMLSchema#string

Tohru Kobayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease

Management of Kawasaki disease.

Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.

Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

P2888

s13643-016-0236-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13643-016-0236-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erika Ota

P577

2016-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301311923

http://www.w3.org/2001/XMLSchema#string

P6179

1010282375

http://www.w3.org/2001/XMLSchema#string

P698

27072358

http://www.w3.org/2001/XMLSchema#string

P932

4830038

http://www.w3.org/2001/XMLSchema#string